Oral Cancer Clinical Trial
Official title:
Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
To obtain data to evaluate whether multispectral digital imaging can assist clinicians to
screen for premalignant lesions in the oral cavity. Our system will illuminate tissue with
monochromatic light to excite fluorescence, and polarized white light to generate
reflectance, exposing abnormalities for real time, clinical diagnosis.
Primary Objectives:
1. To compare fluorescence images of oral mucosa lesions, obtained at 350 nm, 380 nm, 400
nm, and 450 nm excitation, to standard white light images and pathologic analysis of
biopsied tissue.
2. To compare reflectance images of oral mucosa lesion, obtained using broadband polarized
light, to standard white light images and pathologic analysis of biopsied tissue.
3. To develop algorithms to discriminate between normal and abnormal tissue
4. To analyze images to determine which type of optical information (or combination
thereof) yields the most diagnostically useful data
All tissue and cells are made of tiny particles that give off small amounts of light. This
light is called fluorescence. Scientists have learned that cancerous cells and normal cells
give off different amounts and different types of fluorescence. Scientists need to better
understand whether fluorescence from the oral cavity (mouth) can be used to tell which cells
are abnormal. This information can help doctors detect pre-cancers.
In order to better understand fluorescence, researchers at the Optical Spectroscopy and
Imaging Lab, Department of Bioengineering, Rice University have developed an instrument that
can collect and analyze fluorescence without surgically removing any tissue or touching the
tissue. This instrument takes pictures of oral cavity fluorescence through a microscope. The
instrument also takes regular live pictures. Scientists hope to study the pictures to better
understand the differences in fluorescence from normal and abnormal cells. The instrument is
a standard medical microscope similar to ones used by doctors in their offices to examine
people's ears. Researchers have attached a special light source to the microscope that
provides different colors of light. In addition, the microscope has a digital camera
attached to it so that the researchers can record what they see with the different light
colors.
In this study, a clinician will use the instrument to take pictures of suspicious and normal
oral cavity lesions. A small sample of the oral lesion (2-4 mm each, the size of a small
eraser) will be removed or biopsied from the areas that are imaged. A portion of both the
suspicious and normal areas will be taken to pathology for evaluation. The biopsy from the
normal appearing area is a biopsy that is additional to those you will receive as part of
your standard of care. Each participant will have 2-4 biopsies performed, depending upon how
many areas the examiner feels may be suspicious. Most people who take part in this study
will be having surgery to remove lesions in the oral cavity anyway, so the biopsies will be
performed at the time of surgery. For those participants who are not scheduled to have
surgery, the biopsies will be performed under local anesthesia in the clinic.
All data will be numerically coded to ensure your confidentiality.
In addition to the pictures taken and the biopsy, a brief interview will be performed by the
clinical research staff to discuss possible past local therapies and your personal history
of tobacco and alcohol use. The interview should take about 10 minutes to complete.
You will not be told of any of the experimental findings. Information confirming the
diagnosis will be made available to your treating physician. After this visit and tissue
collection, your participation in this study will be complete.
This is an investigational study. A total of 45 patients will take part in this study. All
will be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06031337 -
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
|
||
Completed |
NCT00158678 -
IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
|
Phase 3 | |
Completed |
NCT00933387 -
A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
|
Phase 2 | |
Enrolling by invitation |
NCT05030597 -
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
|
N/A | |
Completed |
NCT03682562 -
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
|
||
Recruiting |
NCT03684707 -
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
|
Phase 4 | |
Recruiting |
NCT06130332 -
Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
|
Phase 2 | |
Recruiting |
NCT04372914 -
Prevention of Oral DNA Damage by Black Raspberries
|
N/A | |
Active, not recruiting |
NCT03529422 -
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
|
Phase 2 | |
Recruiting |
NCT03686020 -
Sensitivity and Specificity of Serum and Salivary CYFRA21-1 in the Detection of Malignant Transformation in Oral Potentially Malignant Mucosal Lesions (Diagnostic Accuracy Study)
|
||
Not yet recruiting |
NCT06060288 -
Diagnostic Accuracy of Mobile Phone Imaging Compared to Conventional Clinical Examination for Oral Cancer Screening
|
||
Withdrawn |
NCT00951470 -
Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
|
N/A | |
Completed |
NCT00964977 -
Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.
|
Phase 3 | |
Completed |
NCT01418118 -
Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery
|
Phase 4 | |
Active, not recruiting |
NCT00232960 -
Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC
|
N/A | |
Recruiting |
NCT05429099 -
Mandibular Reconstruction Preplanning (ViPMR)
|
Phase 2/Phase 3 | |
Completed |
NCT04614896 -
Use of Ultrasound for Measuring Size of Oral Tongue Cancers
|
N/A | |
Recruiting |
NCT03685409 -
Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions
|
Phase 3 | |
Completed |
NCT00402779 -
Erlotinib Prevention of Oral Cancer (EPOC)
|
Phase 3 | |
Recruiting |
NCT05153733 -
Improved Implant for Reconstruction Purposes After Mandibular Resection
|
N/A |